minimum 98% by achiral HPLC and minimum 97% by chiral HPLC

minimum 98% by achiral HPLC and minimum 97% by chiral HPLC

Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help expedite drugs to market. We offer unrivaled expertise in synthesis and separations services to advance your active pharmaceutical ingredients (API) from initial process development and scale-up development, to final validation and commercial manufacturing. From our extensive organic chemistry expertise and collegiate collaborations, we can deliver the added value of our innovative, proprietary chromatography products, especially those with a chiral emphasis. And, we continue to offer fine organic chemicals as we have for almost 50 years. So consider Regis an important partner in your drug development processes. We thrive on the challenges that these projects bring.